• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

门脉高压大鼠肠道-脑趋化因子变化。

Gut-brain chemokine changes in portal hypertensive rats.

机构信息

Department of Surgery I, School of Medicine, Complutense University of Madrid, Plaza de Ramón y Cajal s.n, 28040, Madrid, Spain.

出版信息

Dig Dis Sci. 2011 Aug;56(8):2309-17. doi: 10.1007/s10620-011-1625-y. Epub 2011 Feb 24.

DOI:10.1007/s10620-011-1625-y
PMID:21347560
Abstract

BACKGROUND

Hepatic encephalopathy is a syndrome whose physiopathology is poorly understood; therefore, current diagnostic tests are imperfect and modern therapy is nonspecific. Particularly, it has been suggested that inflammation plays an important role in the pathogenesis of portal hypertensive encephalopathy in the rat.

AIM

We have studied an experimental model of portal hypertension based on a triple partial portal vein ligation in the rat to verify this hypothesis.

METHODS

One month after portal hypertension we assayed in the splanchnic area (liver, small bowel and mesenteric lymph nodes) and in the central nervous system (hippocampus and cerebellum) fractalkine (CX3CL1) and stromal cell-derived factor alpha (SDF1-α) as well as their respective receptors (CX3CR1 and CXCR4) because of their key role in inflammatory processes.

RESULTS

The significant increase of fractalkine in mesenteric lymph nodes (P<0.05) and its receptor (CX3CR1) in the small bowel (P<0.05) and hippocampus (P<0.01), associated with the increased expression of SDF1-α in the hippocampus (P<0.01) and the cerebellum (P<0.01) suggest that prehepatic portal hypertension in the rat induces important alterations in the expression of chemokines in the gut-brain axis.

CONCLUSION

The present study revealed that portal hypertension is associated with splanchnic-brain inflammatory alterations mediated by chemokines.

摘要

背景

肝性脑病是一种发病机制尚不完全清楚的综合征;因此,目前的诊断测试并不完善,现代治疗也没有针对性。特别是,有人提出炎症在门静脉高压性脑病大鼠发病机制中起重要作用。

目的

我们研究了一种基于大鼠三重部分门静脉结扎的门静脉高压实验模型,以验证这一假说。

方法

门静脉高压 1 个月后,我们在大鼠内脏区(肝脏、小肠和肠系膜淋巴结)和中枢神经系统(海马体和小脑)中检测了趋化因子 fractalkine (CX3CL1) 和基质细胞衍生因子 alpha (SDF1-α) 及其各自的受体 (CX3CR1 和 CXCR4),因为它们在炎症过程中起着关键作用。

结果

肠系膜淋巴结 fractalkine 的显著增加(P<0.05)及其受体(CX3CR1)在小肠(P<0.05)和海马体(P<0.01)的增加,与海马体(P<0.01)和小脑(P<0.01)中 SDF1-α的表达增加相关,提示大鼠前肝门静脉高压诱导了肠-脑轴中趋化因子表达的重要改变。

结论

本研究表明,门静脉高压与通过趋化因子介导的内脏-大脑炎症改变有关。

相似文献

1
Gut-brain chemokine changes in portal hypertensive rats.门脉高压大鼠肠道-脑趋化因子变化。
Dig Dis Sci. 2011 Aug;56(8):2309-17. doi: 10.1007/s10620-011-1625-y. Epub 2011 Feb 24.
2
Interactions of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury.趋化因子与趋化因子受体的相互作用介导了舌下神经损伤后间充质干细胞向脑损伤部位的迁移。
Stem Cells. 2004;22(3):415-27. doi: 10.1634/stemcells.22-3-415.
3
Prehepatic portal hypertension produces increased mast cell density in the small bowel and in mesenteric lymph nodes in the rat.肝前性门静脉高压会使大鼠小肠和肠系膜淋巴结中的肥大细胞密度增加。
J Gastroenterol Hepatol. 2005 Jul;20(7):1025-31. doi: 10.1111/j.1440-1746.2005.03831.x.
4
Interactions between chemokine and mu-opioid receptors: anatomical findings and electrophysiological studies in the rat periaqueductal grey.趋化因子与μ-阿片受体相互作用:在大鼠中脑导水管周围灰质中的解剖学发现和电生理学研究。
Brain Behav Immun. 2011 Feb;25(2):360-72. doi: 10.1016/j.bbi.2010.10.020. Epub 2010 Oct 23.
5
Prophylaxis with ketotifen in rats with portal hypertension: involvement of mast cell and eicosanoids.酮替芬对大鼠门静脉高压的预防作用:肥大细胞和类花生酸的参与
Hepatobiliary Pancreat Dis Int. 2008 Aug;7(4):383-94.
6
Expression of the chemokines CXCL12 and CX3CL1 and their receptors in human nerve sheath tumors.趋化因子 CXCL12 和 CX3CL1 及其受体在人神经鞘瘤中的表达。
Histol Histopathol. 2013 Oct;28(10):1337-49. doi: 10.14670/HH-28.1337. Epub 2013 May 6.
7
Mast cell inhibition by ketotifen reduces splanchnic inflammatory response in a portal hypertension model in rats.酮替芬对肥大细胞的抑制作用可减轻大鼠门静脉高压模型中的内脏炎症反应。
Exp Toxicol Pathol. 2008 Aug;60(4-5):347-55. doi: 10.1016/j.etp.2008.03.008. Epub 2008 Jun 2.
8
Ginsenoside Rg1 prevents vascular intimal hyperplasia involved by SDF-1α/CXCR4, SCF/c-kit and FKN/CX3CR1 axes in a rat balloon injury.人参皂苷 Rg1 通过 SDF-1α/CXCR4、SCF/c-kit 和 FKN/CX3CR1 轴预防大鼠血管损伤后内膜增生。
J Ethnopharmacol. 2020 Oct 5;260:113046. doi: 10.1016/j.jep.2020.113046. Epub 2020 Jun 3.
9
Spatial and temporally restricted expression of chemokines and chemokine receptors in the developing human kidney.趋化因子和趋化因子受体在发育中的人类肾脏中的时空限制性表达。
J Am Soc Nephrol. 2002 Apr;13(4):957-967. doi: 10.1681/ASN.V134957.
10
Splanchnic-aortic inflammatory axis in experimental portal hypertension.实验性门静脉高压症内脏-主动脉炎症轴。
World J Gastroenterol. 2013 Nov 28;19(44):7992-9. doi: 10.3748/wjg.v19.i44.7992.

引用本文的文献

1
Target Dysbiosis of Gut Microbes as a Future Therapeutic Manipulation in Alzheimer's Disease.肠道微生物的靶向失调作为阿尔茨海默病未来的治疗手段
Front Aging Neurosci. 2020 Oct 6;12:544235. doi: 10.3389/fnagi.2020.544235. eCollection 2020.
2
The Direct Contribution of Astrocytes and Microglia to the Pathogenesis of Hepatic Encephalopathy.星形胶质细胞和小胶质细胞对肝性脑病发病机制的直接贡献。
J Clin Transl Hepatol. 2019 Dec 28;7(4):352-361. doi: 10.14218/JCTH.2019.00025. Epub 2019 Nov 13.
3
Elevated Systemic L-Kynurenine/L-Tryptophan Ratio and Increased IL-1 Beta and Chemokine (CX3CL1, MCP-1) Proinflammatory Mediators in Patients with Long-Term Titanium Dental Implants.

本文引用的文献

1
Physiopathology of splanchnic vasodilation in portal hypertension.门静脉高压症内脏血管扩张的病理生理学
World J Hepatol. 2010 Jun 27;2(6):208-20. doi: 10.4254/wjh.v2.i6.208.
2
Encephalopathy assessment in children with extra-hepatic portal vein obstruction with MR, psychometry and critical flicker frequency.磁共振成像、心理测量和临界闪烁频率在肝外门静脉阻塞儿童肝性脑病评估中的应用。
J Hepatol. 2010 Mar;52(3):348-54. doi: 10.1016/j.jhep.2009.12.012. Epub 2010 Jan 6.
3
Hepatic encephalopathy: current management strategies and treatment, including management and monitoring of cerebral edema and intracranial hypertension in fulminant hepatic failure.
长期钛牙种植患者的全身L-犬尿氨酸/L-色氨酸比值升高以及白细胞介素-1β和趋化因子(CX3CL1、单核细胞趋化蛋白-1)促炎介质增加。
J Clin Med. 2019 Sep 2;8(9):1368. doi: 10.3390/jcm8091368.
4
Embrionary way to create a fatty liver in portal hypertension.门静脉高压症中创建脂肪肝的胚胎学途径。
World J Gastrointest Pathophysiol. 2017 May 15;8(2):39-50. doi: 10.4291/wjgp.v8.i2.39.
5
Fractalkine suppression during hepatic encephalopathy promotes neuroinflammation in mice.肝性脑病期间趋化因子的抑制会促进小鼠的神经炎症。
J Neuroinflammation. 2016 Aug 26;13(1):198. doi: 10.1186/s12974-016-0674-8.
6
Portal hypertension as immune mediate disease.门静脉高压作为免疫介导性疾病。
Hepat Mon. 2014 Jun 7;14(6):e18625. doi: 10.5812/hepatmon.18625. eCollection 2014 Jun.
肝性脑病:当前的管理策略和治疗,包括暴发性肝衰竭中脑水肿和颅内高压的管理和监测。
Curr Opin Anaesthesiol. 2010 Apr;23(2):121-7. doi: 10.1097/ACO.0b013e32833724c3.
4
Hippocampo-cerebellar theta band phase synchrony in rabbits.兔海马-小脑θ频段相位同步。
Neuroscience. 2010 Feb 17;165(4):1538-45. doi: 10.1016/j.neuroscience.2009.11.044. Epub 2009 Nov 27.
5
Structural features of ischemic damage in the hippocampus.海马体缺血性损伤的结构特征。
Anat Rec (Hoboken). 2009 Dec;292(12):1914-21. doi: 10.1002/ar.20969.
6
Ammonia and the neutrophil in the pathogenesis of hepatic encephalopathy in cirrhosis.氨和中性粒细胞在肝硬化肝性脑病发病机制中的作用。
Hepatology. 2010 Mar;51(3):1062-9. doi: 10.1002/hep.23367.
7
Bacterial translocation to mesenteric lymph nodes increases in chronic portal hypertensive rats.慢性门脉高压大鼠肠系膜淋巴结细菌易位增加。
Dig Dis Sci. 2010 Aug;55(8):2244-54. doi: 10.1007/s10620-009-1001-3. Epub 2009 Oct 16.
8
The value of microsurgery in liver research.显微外科手术在肝脏研究中的价值。
Liver Int. 2009 Sep;29(8):1132-40. doi: 10.1111/j.1478-3231.2009.02078.x. Epub 2009 Jul 6.
9
Hepatic encephalopathy: pathophysiology and emerging therapies.肝性脑病:病理生理学与新兴疗法
Med Clin North Am. 2009 Jul;93(4):819-36, vii. doi: 10.1016/j.mcna.2009.03.009.
10
Glutamine synthetase activity and glutamate uptake in hippocampus and frontal cortex in portal hypertensive rats.门静脉高压大鼠海马和额叶皮质中谷氨酰胺合成酶活性及谷氨酸摄取情况
World J Gastroenterol. 2009 Jun 21;15(23):2893-9. doi: 10.3748/wjg.15.2893.